Dr. Biyuan Zhang 张碧媛
Oncology · Chief Physician, Associate Professor
Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao
Public profile Compiled from public sources. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionCurrent positions
- Head, Radiation Oncology (Laoshan campus)
Checked against a public report (检索 2026-11-15). Positions change; the hospital's website is the final word.
Clinical focus: Radiation therapy, chemotherapy, targeted therapy, and immunotherapy for lung cancer, breast cancer, esophageal cancer, gastrointestinal tumors, and hepatobiliary and pancreatic tumors.
Conditions and procedures: Lung cancer, Breast cancer, Esophageal cancer, Gastrointestinal tumors, Hepatobiliary tumors, Pancreatic tumors
From the doctor's own description on a public doctor-listing platform.
Name order: in Chinese the family name comes first (Zhang Biyuan). Papers usually list the name as Biyuan Zhang.
Selected publications
8 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (8 since 2016). Most recent:
- BMC Cancer, 2025 (senior author): The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma. PubMed 39819558
- Acad Radiol, 2024 (first author): Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer. PubMed 37914627
- Front Oncol, 2023 (senior author): Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients. PubMed 38357424
- Am J Transl Res, 2021 (senior author): CCR10/CCL27 crosstalk regulates cell metastasis via PI3K-Akt signaling axis in non-small-cell lung cancer. PubMed 34956534
- Minerva Med, 2020 (first author): MicroRNA-1307-3p promotes lung cancer cell proliferation by targeting EGFR. PubMed 31256580
- IUBMB Life, 2020 (senior author): Quercetin radiosensitizes non-small cell lung cancer cells through the regulation of miR-16-5p/WEE1 axis. PubMed 32027086
- Cancer Manag Res, 2019 (senior author): The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity. PubMed 31303789
- Minerva Med, 2019 (first author): Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC. PubMed 30784252
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation. See the full PubMed search.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and recommend a treatment plan.
Get a specialist opinion